Compugen Ltd. (CGEN) PT Set at $14.00 by FBR & Co
May 23, 2017 - Watch List News

Compugen Ltd. (NASDAQ:CGEN) has been given a $14.00 price objective by equities research analysts at FBR & Co in a research report issued on Friday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. FBR & Co’s target price indicates a potential upside of 177.23% from the company’s current price. Compugen (NASDAQ:CGEN) opened at 5.05 on Friday … (continue reading)

Would you like to track this news?

Click one of the buttons below or search.

Advanced Options | Search Tips